title: Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
abstract: Cellular immune response plays an important role in antiviral immunity. In our previous study, immunization of mice with severe acute respiratory syndrome coronavirus (SARS CoV) spike (S) DNA vaccine could induce both humoral and cellular immunity in response to a pool of entire overlapping S peptides. Identification of functional dominant epitopes in SARS CoV S protein for T cells is crucial for further understanding of cellular immune responses elicited by SARS CoV S DNA vaccine. In present study, mice were immunized with SARS CoV S DNA vaccine. Subsequently, a pool of 17-19 mers overlapped SARS CoV S peptides, which served as immunogens, were scanned to identify the specific epitopes for T cells. Two H-2(d) restricted CD4(+) T epitopes, N60 (S435-444) and P152 (S1111-1127), and two H-2(d) restricted CD8(+) T cell epitopes, N50 (S365-374) and P141 (S1031-1047) were identified by three different methods, enzyme-linked immunosorbent assay (ELISA), enzyme linked immunospot assay (ELISPOT) and fluorescence activated cell sorter (FACS). The dominant CD4(+) T cell epitope (N60) and CD8(+) T cell epitope (N50) located in the receptor-binding domain (RBD) of SARS CoV S protein, which mediated virus combining and fusing to susceptible cells. Importantly, our novel finding is that mice primed with SARS S DNA vaccine and boosted with T cell epitopes (N50 and N60) could promote antigen specific CD4(+) and CD8(+) T cell immune responses. Our study provides valuable information for the design of vaccine for SARS study.
authors: Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
authors: Jun
authors: J
authors: Huang
authors: Yingnan
authors: Y
authors: Cao
authors: Jiali
authors: J
authors: Du
authors: Xianzhang
authors: X
authors: Bu
authors: Rui
authors: R
authors: Ma
authors: Changyou
authors: C
authors: Wu
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D005260:Female; D007114:Immunization; D007117:Immunization, Secondary; D016056:Immunodominant Epitopes; D007156:Immunologic Memory; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology*; D045169:Severe Acute Respiratory Syndrome / Q000276:immunology / Q000517:prevention & control; D064370:Spike Glycoprotein, Coronavirus; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology; D014759:Viral Envelope Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology
chemical_list: D018984:Epitopes, T-Lymphocyte; D016056:Immunodominant Epitopes; D008562:Membrane Glycoproteins; D010455:Peptides; D064370:Spike Glycoprotein, Coronavirus; D019444:Vaccines, DNA; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C578557:spike glycoprotein, SARS-CoV; C578553:spike protein, mouse hepatitis virus
references: Virology. 1999 Feb 1;254(1):50-60
references: 9927573
references: Emerg Infect Dis. 2005 Jul;11(7):1016-20
references: 16022774
references: Lancet. 2004 Jun 26;363(9427):2122-7
references: 15220033
references: J Exp Med. 2003 Dec 15;198(12):1797-806
references: 14662907
references: J Mol Recognit. 1993 Jun;6(2):81-94
references: 7508238
references: J Infect Dis. 2004 Sep 15;190(6):1119-26
references: 15319862
references: J Virol. 2004 Jul;78(13):6938-45
references: 15194770
references: Curr Opin Immunol. 2003 Aug;15(4):461-70
references: 12900280
references: Trends Immunol. 2004 Feb;25(2):98-104
references: 15102369
references: J Virol. 2005 Nov;79(22):13915-23
references: 16254327
references: J Immunol. 2006 Aug 15;177(4):2138-45
references: 16887973
references: Microbes Infect. 2005 Mar;7(3):427-36
references: 15784184
references: Science. 2003 May 30;300(5624):1394-9
references: 12730500
references: Virology. 2005 Apr 25;335(1):34-45
references: 15823604
references: Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52
references: 15530413
references: Lancet. 2003 Apr 19;361(9366):1319-25
references: 12711465
references: J Virol. 2004 Jun;78(11):5612-8
references: 15140958
references: J Exp Med. 2005 Jul 4;202(1):123-33
references: 15983064
references: Vaccine. 2006 Jun 29;24(26):5498-508
references: 16725238
references: Vaccine. 2005 Aug 15;23(35):4385-91
references: 16005746
references: J Virol. 2006 Feb;80(4):2034-44
references: 16439559
references: Clin Immunol. 2006 Aug;120(2):171-8
references: 16781892
references: Blood. 2004 Jul 1;104(1):200-6
references: 15016646
references: J Biol Chem. 2004 Jan 30;279(5):3197-201
references: 14670965
references: Microbes Infect. 2006 Aug;8(9-10):2424-31
references: 16844400
references: Nature. 2003 Nov 27;426(6965):450-4
references: 14647384
references: J Comb Chem. 2005 Sep-Oct;7(5):648-56
references: 16153058
references: Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53
references: 15496474
references: N Engl J Med. 2003 May 15;348(20):1967-76
references: 12690091
references: J Virol. 2004 Jun;78(12):6134-42
references: 15163706
references: Clin Microbiol Infect. 2004 Jul;10(7):676-8
references: 15214887
references: J Virol. 2004 Nov;78(22):12672-6
references: 15507655
references: Nat Immunol. 2003 Dec;4(12):1191-8
references: 14625547
references: Virology. 2006 Aug 1;351(2):466-75
references: 16690096
references: Nature. 2003 Feb 20;421(6925):852-6
references: 12594515
references: Nat Med. 2005 Aug;11(8):875-9
references: 16007097
references: Virology. 2007 Mar 15;359(2):264-74
references: 17055022
references: Nature. 2004 Apr 1;428(6982):561-4
references: 15024391
references: Vaccine. 2006 Jun 5;24(23):4905-13
references: 16621188
references: J Immunol. 2005 Oct 1;175(7):4686-96
references: 16177116